Stocks of Ardent Health Partners Inc (ARDT) are poised to climb above their peers

With 0.1 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.37 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $16.4253 whereas the lowest price it dropped to was $15.94. The 52-week range on ARDT shows that it touched its highest point at $20.72 and its lowest point at $14.57 during that stretch. It currently has a 1-year price target of $22.50.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ARDT was down-trending over the past week, with a drop of -3.04%, but this was down by -14.76% over a month.

Float and Shares Shorts:

At present, 143.26 million ARDT shares are outstanding with a float of 22.99 million shares on hand for trading. On 2024-11-15, short shares totaled 0.57 million, which was 40.0 higher than short shares on 1728950400. In addition to Mr. Martin J. Bonick FACHE, M.H.A. as the firm’s President, CEO & Director, Mr. Alfred Lumsdaine CPA serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 1.25771 of ARDT’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, ARDT reported revenue of $1449817000.0 and operating income of $70379000.0. The EBITDA in the recently reported quarter was $109957000.0 and diluted EPS was $0.19.

Analysts Ratings:

In the same way, a target price assigned to a stock can also reveal much about its potential. With ARDT analysts setting a high price target of 27.0 and a low target of 19.0, the average target price over the next 12 months is 22.5. Based on these targets, ARDT could surge 69.39% to reach the target high and rise by 19.2% to reach the target low. Reaching the average price target will result in a growth of 41.15% from current levels.

Analysts have provided yearly estimates in a range of $1.33 being high and $1.06 being low. For ARDT, this leads to a yearly average estimate of $1.25. Based on analyst estimates, the high estimate for the next quarter is $0.51 and the low estimate is $0.33. The average estimate for the next quarter is thus $0.39.